Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Metagenomi Therapeutics, Inc. | 187,375 | reported | 05 Mar 2026 | tx 12+578,766−15,941 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Mar 2026 | SALE | Metagenomi Therapeutics, Inc. | 1,581 | 1.60 USD | |
| 05 Dec 2025 | SALE | Metagenomi Therapeutics, Inc. | 1,576 | 1.77 USD | |
| 05 Sept 2025 | SALE | Metagenomi Therapeutics, Inc. | 1,576 | 1.81 USD | |
| 01 Dec 2025 | GRANT_AWARD | Metagenomi Therapeutics, Inc. | 120,000 | 1.60 USD | |
| 06 Jun 2025 | SALE | Metagenomi Therapeutics, Inc. | 1,576 | 1.75 USD | |
| 01 Apr 2025 | GRANT_AWARD | Metagenomi Therapeutics, Inc. | 14,000 | 0.00 USD | |
| 01 Apr 2025 | GRANT_AWARD | Metagenomi Therapeutics, Inc. | 84,000 | 0.00 USD | deriv |
| 05 Mar 2025 | SALE | Metagenomi Therapeutics, Inc. | 1,808 | 1.87 USD | |
| 05 Dec 2024 | SALE | Metagenomi Therapeutics, Inc. | 1,559 | 1.86 USD | |
| 05 Sept 2024 | SALE | Metagenomi Therapeutics, Inc. | 6,265 | 2.88 USD | |
| 01 Apr 2024 | GRANT_AWARD | Metagenomi Therapeutics, Inc. | 69,316 | 0.00 USD | |
| 01 Apr 2024 | GRANT_AWARD | Metagenomi Therapeutics, Inc. | 291,450 | 0.00 USD | deriv |